The Board of Directors of the Company at its Meeting held today i.e. 13th November, 2025, has inter alia, considered, approved and recommended the Un-audited Financial Results (Standalone and Consolidated) of the Company for the quarter and six months ended on 30th September, 2025 along with the Limited Review Report(s) thereon and allotment of 10,00,000 equity shares pursuant to conversion of share warrants issued on preferential basis.